Jazz Pharmaceuticals Announces Participation in Two Upcoming Investor Conferences
May 18 2016 - 4:05PM
PR Newswire (US)
DUBLIN, May 18, 2016 /PRNewswire/ -- Jazz
Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company
will be webcasting its corporate presentations at two upcoming
investor conferences.
- UBS Global Healthcare Conference in New York, NY on Wednesday, May 25, 2016 at 10:00 a.m. EDT / 3:00 p.m.
IST. Matt Young, executive
vice president and chief financial officer, will provide an
overview of the company and a business and financial update.
- Goldman Sachs 37th Annual Global Healthcare
Conference in Rancho Palos Verdes,
CA on Wednesday, June 8, 2016
at 11:20 a.m. PDT / 7:20 p.m. IST. Russell
Cox, executive vice president and chief operating officer,
will provide an overview of the company and a business and
financial update.
A live audio webcast of each presentation may be accessed from
the Investors section of the Jazz Pharmaceuticals website at
www.jazzpharmaceuticals.com. Please connect to the website
prior to the start of the presentation to ensure adequate time for
any software downloads that may be necessary to listen to the
webcast.
An archive of the webcast will be available for at least one
week following the presentation on the Investors section of the
company's website at www.jazzpharmaceuticals.com.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc
(Nasdaq: JAZZ) is an international biopharmaceutical company
focused on improving patients' lives by identifying, developing and
commercializing meaningful products that address unmet medical
needs. The company has a diverse portfolio of products and product
candidates, with a focus in the areas of sleep and
hematology/oncology. In these areas, Jazz Pharmaceuticals markets
Xyrem® (sodium oxybate) oral solution, Erwinaze® (asparaginase
Erwinia chrysanthemi) and Defitelio® (defibrotide sodium) in
the U.S. and markets Erwinase® and Defitelio® (defibrotide) in
countries outside the U.S. For more information, please visit
www.jazzpharmaceuticals.com.
Logo -
http://photos.prnewswire.com/prnh/20150930/272253LOGO
Copyright 2016 PR Newswire
Jazz Pharmaceuticals (NASDAQ:JAZZ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Jazz Pharmaceuticals (NASDAQ:JAZZ)
Historical Stock Chart
From Apr 2023 to Apr 2024